Brief: Q Biomed Inc. Chemotherapeutic Uttroside B, Receives Patent From United States Patent Office And Notice Of Allowance For Europe
14/04/2023 15:16
April 14 (Reuters) - Q BioMed Inc QBIO.PK :
* Q BIOMED INC. CHEMOTHERAPEUTIC UTTROSIDE B, RECEIVES
PATENT FROM
UNITED STATES PATENT OFFICE AND NOTICE OF ALLOWANCE FOR EUROPE
Source text for Eikon: ID:nPn6P0sgSa
Further company coverage: QBIO.PK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Q BioMed
See all newsBrief: Q Biomed Inc. Chemotherapeutic Uttroside B, Receives Patent From United States Patent Office And Notice Of Allowance For Europe
Brief: Q Biomed Provides Shareholder Update
Brief: Q Biomed Announces Publication Of Research Showing Augmented Efficacy Of Its Drug Candidate Uttroside-B Against Liver Cancer
Brief: Q BioMed Inc Updates On COVID-19 Therapeutic Development And Clinical Trials
Brief: Q Biomed To Scale Up Production Of Uttroside-B